Intercept Pharmaceutical Analysis

Superior Essays
Meeting the manufacturing requirements is imperative to the success and profitability of a company. One of the most notable differences with a drug production is the amount of time needed to produce the drug, as described below with Intercept’s newest FDA approved medication, Ocaliva. Cycle time is the time starting when an operation begins to the point of time when the operation ends (Eshna, 2017). Takt time is the maximum acceptable time to meet the demands of the customer, or the speed with which the product needs to be created in order to satisfy the needs of the customer (Eshna, 2017). The takt time formula is below:
Net time available for production / Customer’s daily demand
Takt time formula with Ocaliva is below:
Cycle time for Ocaliva 14 years
Life expectancy upon PBC diagnosis (takt time) 16 years
Cycle time / takt time 14 / 16 = .875

On average, it takes a new medication approximately 10 years to complete the full cycle from initial discovery to FDA approval on market shelves. Ocaliva was initially discovered by Professor Roberto Pellicciari in the 1990’s in Italy. It was not until the inception of Intercept Pharmaceuticals in 2002 that the
…show more content…
This starts with a lab to study the newly discovered compound. This lab and its personnel will examine and test the compound microscopically and on animals to determine its effect on the body. While this testing is being done, Intercept Pharmaceuticals will need to collaborate with the FDA, physicians and scientists to write a protocol for testing the drug on humans. After FDA’s approval of the protocol, Intercept will invite different hospitals to join the study and work with a clinical research office (CRO) to complete the logistics and regulatory aspects of the trial. The CRO is responsible for ensuring the trial is completed within legal parameters and the parameters set by the protocol

Related Documents

  • Improved Essays

    Early stage biotechnology companies like Nucleon require a large capital, and also have a very large risk factor attached to them. After the massive amount of resources invested in preclinical and clinical trials, there is a high chance that the product will never even come out into the market (only 20% of compounds tested in clinical trials get approved by the FDA1). Especially for small companies, it is better to choose a low-risk market strategy. That is why, if I was in Robert Moore’s shoes I would recommend that Nucleon not build a pilot plant to supply CRP-1 for Phase I and II trials. Building a pilot plant has a lot of pros: scaling up would be easier, it would enable the company to develop a robust large scale in-house manufacturing plant in the future, it would build the team’s experience in manufacturing, and the control over the process and quality control of the product would remain with Nucleon.…

    • 822 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    The next incident we see of Miss Emily being manipulative through the people of Jefferson’s opinion of her is when she visits the druggist to buy poison. When she meets the druggist, she is direct with her desire: “I want some poison” (519). When she buys the arsenic, she refuses to tell the druggist her intent for it even though the law requires her to do so (520). The druggist presses her no further indicating that he knows she will have her way no matter what. He labels the arsenic “for rats” but is clearly skeptical of its actual purpose since he refuses to bring her the package himself and does not return.…

    • 146 Words
    • 1 Pages
    Improved Essays
  • Improved Essays

    Medication Synthesis Week Nine The patient is a thirty-two-year-old African American female who has been taking phentermine/topiramate orally for weight loss. She is five foot two inches tall and weighs two hundred and twenty-five pounds. This puts her body mass index at all 41.1, which categorizes her as morbidly obese (NHLBI, 2017).…

    • 447 Words
    • 2 Pages
    Improved Essays
  • Decent Essays

    The non-profit entity Calibr was created by Merck and has about 150 scientists working directly This will enable basic biomedical research for Merck and drug discovery tools for academics This initiative would provide scientists with the required medicinal chemistry and pharmacology tools in order to develop a drug Unlike Pfizer’s CTI, Calibr is not associated with a particular association Academics can submit proposals, which will then be reviewed by a scientific advisory board Calibr will not have a specific therapeutic focus Merck, has the option of an exclusive licence on any proteins or small-molecule therapeutics…

    • 95 Words
    • 1 Pages
    Decent Essays
  • Decent Essays

    kidney failure) Rarity: Not many alternatives for burn victim treatment (assumption based on the case’s voice); large molecule research is still new and rare, tough to get into. Imitability: Not very imitable, especially if Nucleon can gain strong patent protection. Also, the slow development time means that even if another firm could mimic a similar drug, it would take time. Organization: Nucleon is currently not organized to begin trials and manufacturing of this drug.…

    • 666 Words
    • 3 Pages
    Decent Essays
  • Improved Essays

    1960s Thalidomide Scare

    • 1072 Words
    • 5 Pages

    Public Health Problem The 1960s “Thalidomide Scare” occurred due to the negligence of pharmaceutical companies, bent on seeking profit regardless of outstanding public health concerns and the limitation of drug regulation by international governments. Thalidomide continues to negatively affect fetuses as a teratogen in underdeveloped nations, like Brazil, where drug surveillance is inadequate (Vianna et el. 2011). Additional societal stigma regarding the demonized drug hinders its availability to be researched and used in beneficial therapies for diseases including leprosy (Naafs 2006).…

    • 1072 Words
    • 5 Pages
    Improved Essays
  • Improved Essays

    Natalizumab Research Paper

    • 1111 Words
    • 5 Pages

    The lifecycle of a drug is its path from discovery to market. This journey involves basic research, the discovery of a compound, preclinical development, increasingly complicated clinical trials in human subjects, regulatory approval, and post-market surveillance. This entire process can take up to 15 years and cost hundreds of millions of euro. (1) For every drug that gets approved by the Food and Drug Administration (FDA) in the US, 5,000 to 10,000 compounds don't make it through the process, making the whole process very costly and financially risky. (1) A drugs lifecycle ends when or if it is taken off the market unless as in the case of natalizumab it is put back on the market again.…

    • 1111 Words
    • 5 Pages
    Improved Essays
  • Improved Essays

    Biosimilar Case Study

    • 1117 Words
    • 5 Pages

    Biosimilar proposed uses must be same as previously approved reference product; the same way of administration, dosage form, and strength as the reference product; and manufacturing process, packaging, labeling, manufacturing facility that meets same standards designed for the assurance of safety, purity, and potency of the biological product. Biosimilar phase III clinical trials based on the equivalency should prove that the future biosimilar will not decrease nor increased activity compared to the reference product. Clinical development of a biosimilar also delivers a rigorous head-to-head comparison with the reference product. A comparative clinical study design for a biosimilar is to investigate clinically meaningful differences between the future product and the reference product. Clinical endpoints can be chosen that can measure clinically significant differences between the future product and the reference product in a comparative clinical study.…

    • 1117 Words
    • 5 Pages
    Improved Essays
  • Improved Essays

    These two methods in the articles described a way to change the regulation of how pharmaceuticals adjust their…

    • 1525 Words
    • 7 Pages
    Improved Essays
  • Superior Essays

    Animal Testing Satire

    • 1112 Words
    • 5 Pages

    Imagine having the choice of life or death left in your hands alone. On one end, there is a rat, who is energetically running to find a hiding spot from the broom sweeping across the floor. On the other end, there is a stay-at-home mom, jumped up on the table, violently stabbing at the rat in attempts to scare it away from her. One of them will die. Most people would choose to save the stay-at-home mother with three children and not have a guilty thought cross their mind.…

    • 1112 Words
    • 5 Pages
    Superior Essays
  • Improved Essays

    Ivacaftor, C24H28N203, is a 4-oxoquinoline-3-carboxamide molecule which consists of five main functional groups: a quinolone, an amide, a phenol, and two tert-butyls. Quinolones are regularly found in anti-biotics, amides are seen in the synthesis of nylon, phenol can be retrieved from coal tar, and tert-butyl groups are big hydrophobic groups found in tert-butyl alcohol (the simplest tertiary alcohol); none of these functional groups were invented or developed first by the parent company of the drug, Vertex. Together though these groups form an extremely expensive medicine for an extremely dangerous disease. Treatment with Ivacaftor had significant and sustained in their lung function in cystic fibrosis [3.2]. The sky high price of brand name…

    • 993 Words
    • 4 Pages
    Improved Essays
  • Decent Essays

    Mixed Drug Research Paper

    • 145 Words
    • 1 Pages

    Drug are very bad because you can died from drugs. There is some people that do drug a mixed beer. There is people that drink a pill and drink beer you get Intoxicated from that. Doing drug can take to bad place like jail. There is people that do not have a house because of drugs.…

    • 145 Words
    • 1 Pages
    Decent Essays
  • Superior Essays

    Clinical trials have been performed at many sites around the world for many years to obtain approvals in multiple countries. The harmonization of regulatory processes developed by the ICH, drug patent laws, and country specific regulations is very important steps towards the product development, such as drug discovery, early development and preclinical testing, clinical trials and marketing authorizations. Nearly every country agrees to accept the ICH technical necessities for registration of pharmaceutical products for human use. Taking this into an account makes very easy to perform worldwide clinical trials by outsourcing and offshoring models to achieve the numerous regulatory and commercial incentives obtainable in many countries. The perfect time to build a regulatory strategy is before submitting an Investigational New Drug (IND) application.…

    • 1496 Words
    • 6 Pages
    Superior Essays
  • Improved Essays

    To mitigate, the pharmacy should only make high volume low cost drugs before lab results are received. This situation is similar to when Mr. Rogo’s factory relocated quality assurance to before the…

    • 1014 Words
    • 5 Pages
    Improved Essays
  • Improved Essays

    The core of the pharmaceutical industry problems consists of the expiration of patents, rising R&D expenses, and uncertainties facing new researched products and their abnormal methods of circulation of returns from said product. As rooted in the topic of this case AstraZeneca upholds the gold of innovatively changing the way medicine reaches patients. When patents are first granted there are procedures that followed before a drug reaches the marketplace. Due to the extended timeframe that is required for clinical trials, studies and organizational processes to tested and developed the revenue phase of the drug decreases (Hitt, Ireland, & Hoskisson, 2015). More specifically after the developed drug is ready for sale the patent remaining on these products are near expiration.…

    • 703 Words
    • 3 Pages
    Improved Essays